SE8704158L - MICROSPHERE, PROCEDURES FOR PREPARING IT AND USING THEREOF - Google Patents

MICROSPHERE, PROCEDURES FOR PREPARING IT AND USING THEREOF

Info

Publication number
SE8704158L
SE8704158L SE8704158A SE8704158A SE8704158L SE 8704158 L SE8704158 L SE 8704158L SE 8704158 A SE8704158 A SE 8704158A SE 8704158 A SE8704158 A SE 8704158A SE 8704158 L SE8704158 L SE 8704158L
Authority
SE
Sweden
Prior art keywords
microsphere
procedures
preparing
microspheres
way
Prior art date
Application number
SE8704158A
Other languages
Swedish (sv)
Other versions
SE8704158D0 (en
Inventor
U Schroeder
G Nyberg
C Lager
Original Assignee
Carbomatrix Ab C O Ulf Schroed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carbomatrix Ab C O Ulf Schroed filed Critical Carbomatrix Ab C O Ulf Schroed
Priority to SE8704158A priority Critical patent/SE8704158L/en
Publication of SE8704158D0 publication Critical patent/SE8704158D0/en
Priority to PCT/SE1988/000560 priority patent/WO1989003674A1/en
Publication of SE8704158L publication Critical patent/SE8704158L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/02—Separating microorganisms from their culture media
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G01N33/5434—Magnetic particles using magnetic particle immunoreagent carriers which constitute new materials per se
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/548—Carbohydrates, e.g. dextran
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/12—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar
    • G01N2400/14—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar alpha-D-Glucans, i.e. having alpha 1,n (n=3,4,6) linkages between saccharide units, e.g. pullulan
    • G01N2400/16—Starch, amylose, amylopectin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2446/00—Magnetic particle immunoreagent carriers
    • G01N2446/20—Magnetic particle immunoreagent carriers the magnetic material being present in the particle core
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2446/00—Magnetic particle immunoreagent carriers
    • G01N2446/30—Magnetic particle immunoreagent carriers the magnetic material being dispersed in the polymer composition before their conversion into particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2446/00—Magnetic particle immunoreagent carriers
    • G01N2446/80—Magnetic particle immunoreagent carriers characterised by the agent used to coat the magnetic particles, e.g. lipids
    • G01N2446/84—Polymer coating, e.g. gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Nanotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Optics & Photonics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)

Abstract

The present invention relates to a way of producing covalently crosslinked microspheres using biologically acceptable polymers and the use of these microspheres.
SE8704158A 1987-10-26 1987-10-26 MICROSPHERE, PROCEDURES FOR PREPARING IT AND USING THEREOF SE8704158L (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE8704158A SE8704158L (en) 1987-10-26 1987-10-26 MICROSPHERE, PROCEDURES FOR PREPARING IT AND USING THEREOF
PCT/SE1988/000560 WO1989003674A1 (en) 1987-10-26 1988-10-24 Microspheres, way of producing said microspheres and the use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8704158A SE8704158L (en) 1987-10-26 1987-10-26 MICROSPHERE, PROCEDURES FOR PREPARING IT AND USING THEREOF

Publications (2)

Publication Number Publication Date
SE8704158D0 SE8704158D0 (en) 1987-10-26
SE8704158L true SE8704158L (en) 1989-04-27

Family

ID=20370007

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8704158A SE8704158L (en) 1987-10-26 1987-10-26 MICROSPHERE, PROCEDURES FOR PREPARING IT AND USING THEREOF

Country Status (2)

Country Link
SE (1) SE8704158L (en)
WO (1) WO1989003674A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5512439A (en) * 1988-11-21 1996-04-30 Dynal As Oligonucleotide-linked magnetic particles and uses thereof
EP0446260B1 (en) * 1988-11-21 1994-03-02 Dynal A.S. Nucleic acid probes
NZ262679A (en) * 1993-02-22 1997-08-22 Vivorx Pharmaceuticals Inc Compositions for in vivo delivery of pharmaceutical agents where the agents are contained in a polymeric shell
US6528067B1 (en) 1993-02-22 2003-03-04 American Bioscience, Inc. Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
US5916596A (en) * 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
US5665382A (en) * 1993-02-22 1997-09-09 Vivorx Pharmaceuticals, Inc. Methods for the preparation of pharmaceutically active agents for in vivo delivery
US6753006B1 (en) 1993-02-22 2004-06-22 American Bioscience, Inc. Paclitaxel-containing formulations
US5650156A (en) * 1993-02-22 1997-07-22 Vivorx Pharmaceuticals, Inc. Methods for in vivo delivery of nutriceuticals and compositions useful therefor
US5439686A (en) * 1993-02-22 1995-08-08 Vivorx Pharmaceuticals, Inc. Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
US5997904A (en) * 1993-02-22 1999-12-07 American Bioscience, Inc. Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
DE4406139A1 (en) * 1994-02-25 1995-08-31 Matthias Werner Oral magnetic depot formulation using extra-corporal site control
NL1006444C2 (en) * 1997-07-01 1999-01-05 Inst Voor Agrotech Onderzoek Encapsulation of active substances.
GB0001450D0 (en) * 2000-01-21 2000-03-08 Genpoint As Cell isolation method
DE10129815A1 (en) * 2001-06-24 2003-01-09 Profos Ag Process for the purification of bacterial cells and cell components
CN101759882B (en) * 2008-12-25 2012-02-29 陕西北美基因股份有限公司 Sephadex magnetic composite particles and preparation and use thereof
GB2470939A (en) * 2009-06-10 2010-12-15 Dna Supernova Ltd Signal amplification microspheres
WO2019037743A1 (en) * 2017-08-22 2019-02-28 中国石油化工股份有限公司 Starch-containing microsphere and preparation method therefor and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3444939A1 (en) * 1984-12-08 1986-06-12 Bayer Ag, 5090 Leverkusen MAGNETIC MICROSPHERES

Also Published As

Publication number Publication date
SE8704158D0 (en) 1987-10-26
WO1989003674A1 (en) 1989-05-05

Similar Documents

Publication Publication Date Title
SE8704158L (en) MICROSPHERE, PROCEDURES FOR PREPARING IT AND USING THEREOF
NO912600L (en) PROCEDURE FOR THE PREPARATION OF AN ADDITION POLYMERIZATION CATALYST.
NO903656L (en) PROCEDURE FOR PREPARING 17BETA-ACYL-4-AZA-5ALFA-ANDROST-1-EN-3-ONER.
MX9203660A (en) HIGH AND -BETA FACTOR RECEPTORS OF TUMOR NECROSIS.
NO904203L (en) PROCEDURE FOR THE PREPARATION OF ADHESIVE POLYMERS.
NO911139D0 (en) PROCEDURE FOR THE PREPARATION OF LOWER OLEFINES.
NO891710L (en) PROCEDURE FOR PREPARING ETHYLENE POLYMERS.
NO881728L (en) PROCEDURE FOR THE PREPARATION OF CROSS-BOND POLYMER PARTICLES.
NO902003D0 (en) PROCEDURE FOR THE PREPARATION OF N-HETEROARYL-4-QUINOLINAMINES.
NO901554D0 (en) PROCEDURE FOR THE PREPARATION OF DINATE-CEFODIZIM.
NO904285D0 (en) PROCEDURE FOR THE PREPARATION OF SUBSTITUTED CARBOXYTETRAHYDROISOKINOLINES.
NO901832L (en) PROCEDURE FOR PREPARING POLYKETON.
NO884018D0 (en) PROCEDURE FOR THE PREPARATION OF A PRE-RADICAL ADDITION POLYMER.
IT1216757B (en) PROCEDURE FOR THE PREPARATION OF IMMIDIZED ACRYLIC POLYMERS.
NO904800D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CARBAMATES.
IT1229501B (en) PROCEDURE FOR THE PREPARATION OF TRIAZINIC POLYMERS.
NO881768D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,3-DIOXANES.
NO884162L (en) PROCEDURE FOR THE PREPARATION OF POLYMER PARTICLES.
NO900969L (en) PROCEDURE FOR THE PREPARATION OF N-ALLYMETATE TRIFLUORMETHYLANILINE.
NO901067L (en) PROCEDURE FOR THE PREPARATION OF TIOPHENES.
NO904060D0 (en) PROCEDURE FOR THE PREPARATION OF SUBSTITUTED DIBENZOFURANES.
IT1230153B (en) PROCEDURE FOR PREPARING 1,1,1 TRIFLUORO-2,2-DICHLOROETANO
IT8722504A0 (en) PROCEDURE FOR THE PREPARATION OF IMMIDIZED ACRYLIC POLYMERS.
IT8922875A0 (en) PROCEDURE FOR THE PREPARATION OF CLOTRIMAZOLE
NO903196L (en) PROCEDURE FOR PREPARING 2-DIAZO-3-TRISUBSTITUTED SILYLOXY-3-BUTENOATES.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8704158-8

Effective date: 19900501

Format of ref document f/p: F